SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-341242
Filing Date
2018-12-03
Accepted
2018-12-03 17:27:06
Documents
7
Period of Report
2018-12-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d667507d8k.htm 8-K 17107
2 EX-99.1 d667507dex991.htm EX-99.1 10613
3 EX-99.2 d667507dex992.htm EX-99.2 26959
4 EX-99.3 d667507dex993.htm EX-99.3 20120
5 GRAPHIC g667507g1204022156782.jpg GRAPHIC 2508
6 GRAPHIC g667507g1204022156985.jpg GRAPHIC 1531
7 GRAPHIC g667507g1204022157079.jpg GRAPHIC 2258
  Complete submission text file 0001193125-18-341242.txt   85166
Mailing Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-50484 | Film No.: 181214842
SIC: 2834 Pharmaceutical Preparations